Shorter‐term and longer‐term mortality prediction in the Australian Diabetes, Obesity and Lifestyle ( AusDiab ) study
Internal Medicine Journal · 2025
DOI: 10.1111/imj.70015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Dunya Tomic und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Life Style, Obesity, Diabetes Mellitus. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck Sharp and Dohme Australia, Abbott Australasia Pty Ltd, Alphapharm Pty Ltd.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
While identification of key risk factors for mortality has contributed to advances in healthcare, the effect of these risk factors in predicting mortality over different time horizons remains unclear.
Aims
We sought to determine how risk factors predicted shorter‐term and longer‐term mortality across the age spectrum in adults.
Methods
We used data from 11 247 adults of the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Cox multivariable regression models were used to estimate hazard ratios (HRs) of shorter‐term (0–10 years) and longer‐term (10–20 years) all‐cause and cardiovascular disease (CVD)‐related mortality associated with risk factors. Models with interaction between baseline age and each risk factor were also fitted.
Results
During a 20‐year follow‐up, 2185 deaths occurred. Smoking, diabetes, male sex and albuminuria all independently predicted shorter‐ and longer‐term all‐cause and CVD mortality. Most associations were stronger in the shorter term compared to the longer term. A notable exception was the association between smoking and CVD mortality, which was stronger in the longer term (HR 3.55, 95% confidence interval (CI) 2.57–4.90) compared to the shorter term (HR 2.06, 95% CI 1.33–3.20). The magnitude of association between most risk factors and mortality attenuated with age.
Conclusions
Classical risk factors for total and CVD mortality remain important up to 20 years after their measurement. In unselected adult cohorts, longer‐term follow‐up (e.g. beyond 10 years) may not provide additional information on associations of risk factors with mortality beyond that obtained in shorter‐term follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
- Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
- School of Mathematics and Statistics, The University of Melbourne, Melbourne, Victoria, Australia.
- Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
- Department of Diabetes, Monash University, Melbourne, Victoria, Australia.
ORCID-Profile: Dunya Tomic
Förderung
- Merck Sharp and Dohme Australia
- Abbott Australasia Pty Ltd
- Alphapharm Pty Ltd
- Amgen Australia
- Pratt Foundation
- Department of Health and Aged Care, Australian Government
- Roche Diagnostics
- Marian & FH Flack Trust
Zitieren
APA
Tomic, D., Salim, A., Barr, E. L. M., Zimmet, P. Z., Magliano, D. J., & Shaw, J. E. (2025). Shorter‐term and longer‐term mortality prediction in the Australian Diabetes, Obesity and Lifestyle ( AusDiab ) study. Internal Medicine Journal. https://doi.org/10.1111/imj.70015
Vancouver
Tomic D, Salim A, Barr ELM, Zimmet PZ, Magliano DJ, Shaw JE. Shorter‐term and longer‐term mortality prediction in the Australian Diabetes, Obesity and Lifestyle ( AusDiab ) study. Internal Medicine Journal. 2025. doi:10.1111/imj.70015
BibTeX
@article{Tomic2025,
author = {Tomic, Dunya and Salim, Agus and Barr, Elizabeth L M and Zimmet, Paul Z and Magliano, Dianna J and Shaw, Jonathan E},
title = {Shorter‐term and longer‐term mortality prediction in the Australian Diabetes, Obesity and Lifestyle ( AusDiab ) study},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.70015}
}
EUVIMED